The current population of older Americans has accumulated substantial lifetime lead doses, which raises concern about the possibility of adverse cognitive outcomes. We evaluated whether cumulative lead dose from environmental exposures is associated with cognitive function and decline, and whether such effects are persistent, reversible, or progressive. Methods: We used longitudinal linear modeling to evaluate associations of tibia lead concentration with cognitive function and decline in sociodemographically diverse, community-dwelling adults aged 50 -70 years who were randomly selected from neighborhoods in Baltimore. Six summary measures of cognitive function were created from standard tests in the following domains: language, processing speed, eye-hand coordination, executive functioning, verbal memory and learning, and visual memory. Results: The mean (SD) tibia lead level was 18.8 (11.6) g/g. In models adjusted for demographic characteristics, socioeconomic status (SES), and race/ethnicity, higher tibia lead was associated with a progressive decline in eye-hand coordination. Tibia lead was associated with persistently impaired cognitive function in all 6 domains, although these associations weakened after increasing covariate control. In fully adjusted stratified analysis among white persons, persistent effects were apparent in eye-hand coordination, executive functioning, and verbal memory and learning.
T here is increasing evidence that lead exposure is associated with adverse cognitive outcomes in adults. 1 This observation has public health importance because during the middle of the 20th Century, the US population was exposed to unprecedented levels of lead in both occupational settings and the general environment-the latter because, before 1980, lead was extensively used in commercial products including gasoline, paint, food cans, and water pipes. [2] [3] [4] As a consequence, the current population of older Americans has accumulated substantial lifetime lead doses. 5, 6 This population is also expected to have longer survival than previous cohorts, so there is the potential that high lead exposure and longer survival could combine to produce a substantially increased level of cognitive impairment. This report from the Baltimore Memory Study 4,7 evaluates whether cumulative lead dose from primarily nonoccupational sources adversely affects cognitive trajectory in 50 -70-year-old adults.
Several cross-sectional and longitudinal studies of occupationally-exposed workers have demonstrated associations between cognitive test scores and recent (blood lead) or cumulative (tibia lead) dose. 1,5,8 -17 There are, however, only 2 such epidemiologic studies of community residents with environmental exposure: the Baltimore Memory Study and the Normative Aging Study. 18 Both have reported crosssectional associations between cumulative lead dose and performance on neurobehavioral tests spanning a variety of cognitive domains, as well as a global cognitive measure (Mini-Mental State Examination score 14 ). In the Normative Aging Study, associations were inconsistent across domains, and in some cases were outlier-dependent. 14, 18 In contrast, associations in the Baltimore Memory Study were consistent across multiple domains, but were substantially attenuated after adjusting for race/ethnicity. 4 The Normative Aging Study has also reported longitudinal associations between cumulative lead dose and adverse changes in Mini-Mental State Examination score and 7 tests measuring attention/ working memory, short-term memory, and visuospatial abil-ity, 18 but most associations were modest. In summary, while the current evidence from general population studies is suggestive, it is sparse, inconsistent and mainly from crosssectional analysis.
This report presents longitudinal analyses that augment existing evidence in 2 ways. First, whereas the Normative Aging Study included primarily white men, 11, 15 the Baltimore Memory Study includes both sexes and is racially and ethnically diverse. In light of the historical and persistent disparities in lead exposure by race/ethnicity and SES, 19, 20 it is important to include disadvantaged subpopulations in research on lead-associated risk. Second, our analyses specifically aimed to distinguish 4 competing hypotheses regarding the associations (absent, reversible, persistent, or progressive) of cumulative lead dose and cognitive decline. 21 
METHODS

Study Population and Design
The Baltimore Memory Study is a longitudinal cohort study of urban-dwelling persons designed to evaluate potential determinants of cognitive decline in mid-and laterlife. 4, 7, 22, 23 In brief, households with telephone numbers in 65 contiguous neighborhoods of Baltimore were randomly selected; 18,826 households were telephoned to assess eligibility and interest in the study. Neighborhoods were diverse in race/ethnicity and socioeconomic profiles. Persons aged 50 -70 years and residing in Baltimore for at least 5 years were eligible. Among the 2351 randomly chosen residents meeting these criteria, 1140 (49%) were subsequently enrolled in the study and completed a first assessment. As previously discussed, 7 we examined the representativeness of our study sample by comparing our study subjects to the distribution of residents in our target neighborhoods by sex and race/ethnicity using 2000 Census data. 24 These data suggested that African-American men were underrepresented and white women overrepresented in our sample. Two main factors could have influenced the representativeness of our study sample regarding race/ethnicity: differential phone ownership and differential participation rates. We could not easily evaluate the first, but for the second, we examined enrollment success in our study neighborhoods by race/ethnicity using 2000 Census data. We found no apparent trend in enrollment success by the proportion of African-Americans in neighborhoods, suggesting that the study subjects were representative of the source population with telephones.
Subjects were scheduled for 2 follow-up visits at approximately 14-month intervals. Of those enrolled, 1033 (91%) completed the second study visit and 943 (83%) completed the third study visit. Of the 197 who did not return for visit 3, 101 (9% of those enrolled) refused, 23 (2%) were too ill, 21 (2%) were deceased, 38 (3%) were lost to followup, and 14 (1%) had moved out of state. All participants provided written informed consent and were paid $50 for their time at each visit. The study was approved by the Committee for Human Research at the Johns Hopkins Bloomberg School of Public Health.
Analytic Outcome: Cognitive Function
At each study visit, participants completed an approximately 90-minute battery of 20 standardized tests to assess a broad range of cognitive domains, provide multiple measures of each domain, and minimize differential item bias by race/ethnicity or SES. 7, 22, 23 In examination of longitudinal univariate summary statistics, we identified a problem with 1 test (the Rey complex figure copy task) that arose due to an unanticipated inconsistency in the scoring procedure after the first study visit. We thus excluded it from the longitudinal analysis and analyzed 6 cognitive domains: language (Boston naming test, letter fluency, category fluency), processing speed (inverse of simple reaction time), eye-hand coordination (Purdue pegboard dominant hand, nondominant hand, and both hands, trail-making test A), executive functioning (Purdue pegboard assembly minus both hands, Stroop C form minus A form, trail-making test B minus A), verbal memory and learning (Rey auditory verbal learning test immediate recall, delayed recall, recognition), and visual memory (Rey complex figure delayed recall, symbol digit). We derived a summary score for each domain by first reversing the signs where necessary to ensure that higher values indicated better performance, then standardizing each test in the domain to a z-score, and finally averaging z-scores across the tests. 4, 25 
Primary Risk Factor: Lifetime Cumulative Lead Dose
The specific aim of this analysis was to characterize associations of cumulative lead dose with cognitive function and decline. Lead accumulates in bone and its residence time in cortical bone is measured in decades. 26, 27 We measured cortical bone (tibia) lead concentration (in units of g lead per gram bone mineral) to estimate cumulative lead dose at visit 2, using 109 Cd K-shell x-ray fluorescence. 28, 29 This is a well-validated and reliable method for measurement of lead in bone 5, 30, 31 ; however, imprecision can result in a negative estimate of the tibia lead concentration for low concentrations. These negative estimates may nonetheless accurately rank persons with respect to their underlying tibia lead concentrations, 32 and so a common practice has been to retain the values for analysis. 4, 5 Early in our analysis, we evaluated the influence of the 45 negative concentrations. Strong associations were observed between variation in these values and cognitive performance in nearly all domains, but, in contrast to associations observed in the non-negative range of concentrations, they suggested improving cognitive function with increasing lead concentration. This raised concern about the validity of these negative values and analyses including them, so they were excluded from most subsequent analyses, leaving 965 individuals. Analyses including all data are provided as an online supplement.
Other Potential Determinants of Cognitive Function or Lead Dose
We sought to control for potential confounders of the lead-cognition relation, which were organized into 2 tiers for adjustment: "base" characteristics (age, sex, neurobehavioral testing technician) and cultural/socioeconomic characteristics (race/ethnicity, educational attainment, household wealth). 7, 33 Age, sex, and race/ethnicity were self-reported, the latter using the categories for the 2000 US Census. Socioeconomic characteristics were assessed using an instrument developed for the study. 7 Educational attainment was assessed as a 9-level ordinal index and household wealth was measured in dollars of income plus assets. 7, 33 
Conceptual Framework
Tibia lead concentrations vary considerably among individuals and are thought to validly and reliably estimate lifetime cumulative dose. For our study subjects, daily lead dosing from environmental sources was high for many decades, peaking around 1970 and then declining. We consider the large-scale reductions in environmental lead levels as an exposure "remission." We evaluated 4 competing hypotheses on the consequences for cognition of such cumulative dose: H 0 (none): Lead dose is not associated with cognitive status or trajectory. H 1 (reversible): Lead dose is associated with cognitive dysfunction but recovery occurs after exposure remission. H 2 (persistent): Higher lead doses are associated with cognitive dysfunction and these decrements persist over time. H 3 (progressive): Higher lead doses are associated with cognitive dysfunction and the magnitude of the decrement increases over time. H 1 and H 3 involve a changing magnitude of decrement over time; we henceforth refer to these as "changing effect" hypotheses.
Statistical Analyses
In initial analyses, we searched for distributional skewing, described crude longitudinal trends and bivariable relationships between cognitive outcomes, time, and other predictor variables, and compared distributions across participant dropout patterns. We validated outlier values. Household wealth was log-transformed. To limit the analytic influence of tibia lead outliers, we truncated the 3 highest outliers (148, 90, and 85 g/g) to the next highest value (63.3 g/g) a priori.
We employed marginal longitudinal linear regression to analyze relationships between lead and cognition (by generalized estimating equations 34, 35 ), allowing "unstructured" serial correlation among the 3 study visits. With approximately normally distributed data, this is nearly equiv-alent to maximum likelihood fitting, which assures robustness of findings to incomplete participation and dropout up to missing-at-random. 36 Q-normal plots suggested approximate normality in the visual memory domain and a slight departure from normality in the other domains. To achieve valid inferences in this scenario, we report tests and confidence intervals employing robust standard errors, using the sandwich estimator. 37 Each domain summary score was separately regressed on tibia lead and other potential determinants identified a priori, as well as time since baseline visit (in years) and interactions between lead and time. Age, lead, and household wealth were modeled as continuous variables, and educational attainment ordinally. Following on findings of attenuation of lead associations in previous studies and as motivated by our study's focus on health disparities, stratified analyses were conducted for white and African-American participants (all others comprised only 5% of our subjects). Bivariable plots suggested threshold and plateau relationships of lead with cognitive outcomes, so these were modeled as a linear spline 38 with a knot at 15 g/g (the approximate nonlinear inflection point). For analyses including negative tibia lead measurements, an additional knot was placed at 0. Relations with log-household-wealth were modeled as a linear spline (knot at 95th percentile, approximately 1 million dollars) to limit the influence of very wealthy households. Models controlling only for base covariates, and then also for cultural/ SES covariates (full model), were compared.
To build our longitudinal models, we first tested the presence of interactions between time and all lead spline terms, using nested model comparison. This distinguishes the hypotheses of "changing" lead effect (progressive or reversible hypotheses) against the hypotheses of stable ("nonchanging") lead effect (persistent or null hypotheses). When we compared findings across base and full models, conclusions were similar. Next, we reported findings or, for a null finding at the first step, proceeded to test for persistent versus no lead effect, using models with no lead-by-time interactions. Results of the latter analysis were also compared across base and full models. The 2 primary hypotheses were evaluated with joint null hypothesis tests for both lead coefficients (main term and spline), or their interactions with time since baseline, using the Wald testing method for generalized estimating equations. 39 Where the lead spline term was not statistically significantly different from 0, we eliminated it to report strengths of association in a simpler model. This procedure yields primary hypothesis tests as free of subjectivity as possible, while allowing simplified interpretation and added precision for description of association strengths where simplification appeared appropriate. Because there is no norm for what constitutes harmful tibia lead exposure, we report associations per interquartile range (IQR) of lead levels in our sample. In our previous cross sectional work, a nearly identical IQR increase in tibia lead concentrations was associated 4 suggesting our selected unit of exposure was clinically meaningful. We undertook extensive model-checking and sensitivity analyses to ensure that our fitted models faithfully represented the data. Residual and partial residual plots were examined. 40 In isolated cases where poor fit was suggested, we enriched models to account for discrepancies. We also conducted analyses assessing test-retest effects (by including both visit indicators and time since baseline), including random effects for resident neighborhood, and constricting household wealth to the range shared by whites and African-Americans. In no case was there a substantive change in findings in the lead-cognition relations.
RESULTS
Description of Study Subjects
Approximately two-thirds of participants were women; 55% were white and 40% were African-American (Table 1) . Participants varied considerably in educational attainment. Mean age was approximately 60 years and geometric mean household wealth was $200,000. The proportion of subjects with complete visit data, those who dropped out of the study after the baseline visit, and those who dropped out after the second visit did not differ by sex (P Ͼ 0.05), but those who dropped out were younger, had a higher proportion of African-Americans, were less well educated, less wealthy, and had higher tibia lead levels. Mean tibia lead concentration (only non-negative values) was 19 g/g with an IQR of 12.7 g/g. Persons with negative tibia lead concentrations (excluded in primary analyses) were approximately 20% more likely to be white and more than 3 times more likely to be of "other" race/ethnicity, they were 1.3 years younger on average and 19% more likely to be female. The associations of wealth and educational attainment with negative lead concentrations were negligible.
Primary Findings
We first distinguished between progressive/reversible (ie, changing) effects and no/persistent (nonchanging) effects by testing for interaction between time and both lead concentration spline terms in models fully adjusted for base and cultural/SES characteristics ( Table 2) . Findings from models adjusted only for base characteristics were qualitatively identical. The tests generally failed to support effect change, except in the eye-hand coordination domain, where compelling support was observed for a progressive effect. Because there was no strong indication for a spline term in this domain, we present linearly modeled effects in Table 3 : baseline associations between domain scores and increasing lead concentrations, and estimates of effect change (linear versions of the spline interactions provided in Table 2 ). We found that the rate of decline in the eye-hand coordination domain z-score per 12.7 g/g (IQR) worsened by 0.019 units per year (95% confidence interval ϭ 0.007-0.031) (Table 3) in the whole cohort; in the African-American cohort, the estimated decline rate worsened by 0.032 units per year per 12.7 g/g (0.012-0.052). We found one additional, but considerably less compelling, indication of changing effect. Among whites, there was a suggestion of an interaction between time and lead dose in the verbal memory and learning domain (departure from parallelism over time illustrated in the Figure; inference for magnitude and significance of the departure, in Table 2 ). For this domain, spline terms were indicated, and thus are retained in Table 3 . Rather than providing clear evidence of progression, the estimated temporal changes suggested lessening practice effect, or convergence in repeated performances, with increasing lead dose, and finally, a crossover into worsening performance over time at the highest lead doses.
In the absence of clear progressive effects (except for eye-hand coordination) or reversible effects, we simplified to a model without time-by-lead interactions and proceeded to distinguish a persistent lead effect from no effect ( Table 4) using "joint" tests for absence of both lead terms (main term and spline for time-invariant association between cognitive outcomes and lead concentration). Because no spline term differed statistically from 0, we report magnitudes of association from the simplified linear models. In analysis of all subjects, findings were similar to those reported previously in cross-sectional analyses, 4 with persistent associations between increasing lead dose and impaired cognitive performance that were large in all domains, but gradually diminished as adjustments for SES and race/ethnicity were made. Effect sizes were reduced by 75% or more with full adjustment for both SES and race/ethnicity. However, stratified analyses provided novel insights in white participants After full adjustment, joint tests were suggestive of a persistent association between increasing lead dose and worsening cognition in the domains of eye-hand coordination, executive functioning, and verbal memory and learning. The upper spline term was not significant for any of these domains; upon its removal, mean cognitive function was found to worsen, for both eye-hand coordination and executive function, by 0.064 z-score points (with confidence The P value evaluates whether there is evidence of a progressive or reversible effect. a Low-lead linear term estimates the yearly change in the adjusted lead relation over lead values between 0 and 15 g/g; high-lead linear spline term estimates the difference between the yearly change in the adjusted lead relation over lead values greater, and less than, 15 g/g. Lead relation is given as units of domain score per 12.7 g/g (IQR) of tibia lead. b Bivariate Wald test for the null hypothesis that both lead coefficients equal 0, with 2 reference distribution (2 degrees of freedom). c The stratified total does not add up to this grand total because 53 subjects of mixed race/ethnicity or other race/ethnicity were not included in the 2 strata. 
DISCUSSION
This study was designed to distinguish among absent, reversible, persistent, and progressive associations of cumulative lead dose on 6 cognitive domains over time. We found that higher tibia lead levels were associated with a progressive decline in eye-hand coordination in the full cohort and in African-American participants. Similar to previous results from the cross-sectional analysis of first-visit data, 4 persistent associations of higher tibia lead concentrations with worse cognitive function were consistently found in all domains. These weakened after increasing control for SES and race/ ethnicity. However, the increased power of the 3 visits of data allowed us to complete a stratified analysis. In whites, even after full adjustment, persistent effects were substantiated in eye-hand coordination, executive functioning, and verbal memory and learning. These robust and consistent findings are the strongest evidence to date concerning cumulative lead dose and cognitive function in adults. They support and augment evidence from the only prior longitudinal study of cumulative Results are presented only for results with associated P Ͻ 0.10 in Table 2 . Relationships are linear except as noted. a The Base Model adjusted for age, sex, and interviewer. b The IQR of tibia lead among individuals with non-negative concentrations (n ϭ 965) is 12.7 g/g. c The race/ethnicity-and SES-adjusted models include all base model adjustments. They do not include race/ethnicity after stratification. d Test for adequacy of linear model was rejected, with 95% CI for spline term Ϫ0.166 to Ϫ0.007; "low to moderate" term estimates the lead relation over lead values between 0 and 15 g/g; "high vs. low/moderate" term estimates the difference between the lead relation over lead values greater, and less than, 15 g/g. 11, 14, 15, 18 That sample, however, was considerably less diverse in its sex and racial/ ethnic composition. Although the strongest findings on persistence were observed in white study subjects, we believe it would be mistaken to conclude that there are not more general implications of the findings. As discussed in our prior crosssectional analyses of this population, 4, 41 there are many possible reasons why associations might attenuate after adjustment for race/ethnicity and SES even if cumulative lead dose contributes to cognitive decline in all subjects (eg, unmeasured effect modification, reciprocal effects 41 ). Detailed additional discussion is beyond the present scope, but other explanations for our failure to substantiate an association of lead among African-Americans (if an underlying association exists) include the "weathering" hypothesis, 42 social stratification, 43 survivor bias and out-selection, 44, 45 cumulative disadvantage, 46 and difficulty in unchaining the effect of a single health insult in the presence of multiple health insults. [47] [48] [49] We believe these considerations leave open the possibility that cumulative lead dose may contribute to decrements in cognitive function in adults regardless of race/ethnicity. Data from multiple visits provide longitudinal evidence. Longitudinal data more strongly support causal inferences than cross-sectional data by establishing temporality and allowing comparisons that treat individuals as their own controls. The strongest inferences in our study were tied to progressive effects, which involve within-person changes in cognitive outcomes over time. These associations were observed only in isolated instances, perhaps due to the relatively short duration of follow-up. The primary benefit of longitudinal data for analyses of persistent effect is to increase precision in characterizing cognitive functioning and, where persistence is observed, demonstrate stability over time in the relations of lead dose and cognitive test scores.
There were several strengths of this study. It is the largest study of bone lead and cognitive decline to date; it randomly selected study subjects to be representative of its sampling frame; it is diverse by sex, race/ethnicity, and SES; it rigorously measured SES; it rigorously assessed cognition in multiple domains; it measured a large number of covariates; it is longitudinal with reasonably successful follow-up; and it employed theoretically driven, state-of-the-art longitudinal analyses. The main limitation was loss of subjects from the studied cohort due to initial refusal to participate, uncompleted or negative tibia lead measurements, and dropout during the study. Loss of data by all of these mechanisms limited the power and precision for analyses, and has the potential to bias findings. Because recruitment achieved our targets and loss to follow-up was at the rate anticipated in initial study design, we do not consider power loss related to sample size to be a primary concern.
Biases are not as easily dismissed, as data loss was systematically related to both demographic factors and tibia lead. It is possible that refusal or dropout could have been related to cognitive status independent of measured characteristics. We consider the most likely scenario of informative data loss to be a higher likelihood of dropout among individuals with impaired cognition, both theoretically and because mean cognitive performance improved over rounds in most domains. We believe such a mechanism would have tended to mask progressive or persistent effects due to loss of individuals with impaired cognition, rather than create spurious ones. By this standard, the persistence findings are particularly compelling. However, it must be noted that the primary analytic plan was to not stratify and that we made multiple comparisons by domains and by strata. Among 18 fullyadjusted joint tests of persistence (6 domains by total, white and African-American samples), 1.8 positive findings are anticipated (at alpha level ϭ 0.10); our 3 positive findings are thus suggestive but not conclusive. There is some further coherence in that all 3 findings were in a single cohort (whites) and were strengthened after eliminating spline terms that were not supported by the data.
We believe it critical that public health researchers continue to characterize the cognitive effects of cumulative lead dose and, if present, evaluate possible interventions to prevent or mitigate them. Our study subjects were born between 1930 and 1950. Lead use in gasoline increased dramatically from 1950 -1970 in the United States, peaking in 1969. 2 We estimate that, during these decades, this use distributed an average of 800,000 g of lead per person per year into the environment. Although general population surveillance studies were not performed until the late 1970s, data within single cities suggest that mean blood lead levels in 1965 were as high as 25 g/dL in the general population. 2 By the time NHANES II measured blood lead levels in the general population in the late 1970s, use of lead in gasoline had declined considerably, but mean blood lead levels still exceeded 15 g/dL across virtually all age and sex groups in the United States. With growing numbers of older Americans achieving increasing life expectancies, population aging will soon collide with the peak lead doses experienced by this cohort. It is therefore critical to characterize the late life consequences of early-, mid, and late-life lead exposures.
Our study contributes to this developing understanding, providing the strongest evidence to date that cumulative lead dose is associated with adverse effects on cognitive function that are at least persistent in nature, decades after the majority of lifetime dose was achieved. While there may be a signal of progressive effect in one cognitive domain, the relatively short follow-up duration and the relatively low average age of study subjects makes conclusions about a progressive effect uncertain at this time. The data suggest that a proportion of what has been termed "normal cognitive aging" may in fact be due to lifetime exposure to neurotoxicants such as lead. As persons with the highest cumulative lead doses age, the role of lead dose on cognitive aging could not only become more apparent but have public health consequences that we are only beginning to understand.
